Invitrogen™ Human TMEM106A Synthetic Peptide
TMEM106A Synthetic Peptide, PEP-1395, from Invitrogen.
- Gene ID (Enter)
- 113277
- Species
- Human
- Purification method
- Purified
- Accession number
- Q96A25
- Common name
- Human TMEM106A
- Brand
- Invitrogen
TMEM106A Synthetic Peptide, PEP-1395, from Invitrogen.
TMEM106A Synthetic Peptide, PEP-1395, from Invitrogen.
Transmembrane protein 106A (TMEM106A) is a single-pass transmembrane protein that is closely related to TMEM106B, a protein that is thought to be a novel risk factor for frontotemporal lobar degeneration (FTLD), a group of clinically, pathologically and genetically heterogeneous disorders associated with atrophy in the frontal lobe and temporal lobe of the brain. The actual roles of TMEM106A and TMEM106B are still undetermined; however, as TMEM106B is involved in FTLD, it is possible that TMEM106A may also be a risk factor for FTLD.
Species: Human.
Storage: -20°C.
Concentration: 200 μg/mL.
Research only (RUO).
Packaging: 50 μg.
| General | |
|---|---|
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15205309 |
| Specifications | |
| Gene ID (Enter) | 113277 |
| Species | Human |
| Purification method | Purified |
| Accession number | Q96A25 |
| Common name | Human TMEM106A |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | TMEM106A |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping | |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
| Manufacturer ref. | PEP-1395 |
|---|---|
| Country of origin | United States |
| HS customs code | 3824 99 92 00 |